secwatch.observer — SEC 8-K summary
======================================

Issuer:     Pasithea Therapeutics Corp. (KTTA)
CIK:        0001841330
Form:       8-K
Filed at:   2023-09-14T23:59:59+00:00
Accession:  0001213900-23-076515
Event type: other_material
Sentiment:  positive
Materiality: 0.70
Item codes: 7.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Pasithea completes tender offer: buys 5.32M shares at $0.70; post-offer shares 20.8M
--------------------------------------------------------------------------------

- All 5,323,451 validly tendered shares accepted for purchase at $0.70 per share, no proration.
- Tender offer expired Sept 8, 2023; funded from cash on hand.
- Post-offer shares outstanding: 20,819,956; CEO notes >8.5M shares repurchased over past 9 months.
- CEO: low tender indicates shareholder confidence; buyback provides liquidity and increases remaining holders' ownership.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1841330/000121390023076515/0001213900-23-076515-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1841330/000121390023076515/ea185161-8k_pasithea.htm
  HTML page:      https://secwatch.observer/filing/0001213900-23-076515

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer